The Respiratory Technology Group links fundamental respiratory science, like molecular pharmacology and cell biology, with clinical research, like physiology, epidemiology and clinical management.
The group, established in 2012, is a leader in the areas of drug formulation, device development, characterisation and delivery.
Researchers work from purpose built state-of-the-art laboratory facilities opened in January 2013.
To learn more about the Respiratory Tech Group you can visit their webpage www.RespiTech.org.